Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidilizumab + Rituximab in Relapsed Follicular Lymphoma
NCT00904722Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2010
- Primary completion
- Apr 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pidilizumab in follicular lymphoma (FL), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2010; status: completed.
02
Drugs
pidilizumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00904722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00904722.